Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) EBITDA (2020 - 2025)

Historic EBITDA for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to -$11.4 million.

  • Rapid Micro Biosystems' EBITDA rose 554.03% to -$11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.4 million, marking a year-over-year increase of 1246.77%. This contributed to the annual value of -$49.9 million for FY2024, which is 1174.62% up from last year.
  • As of Q3 2025, Rapid Micro Biosystems' EBITDA stood at -$11.4 million, which was up 554.03% from -$12.1 million recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' EBITDA ranged from a high of -$9.7 million in Q1 2021 and a low of -$17.3 million during Q4 2022
  • In the last 5 years, Rapid Micro Biosystems' EBITDA had a median value of -$13.4 million in 2024 and averaged -$13.3 million.
  • As far as peak fluctuations go, Rapid Micro Biosystems' EBITDA crashed by 8067.2% in 2021, and later soared by 2938.59% in 2023.
  • Over the past 5 years, Rapid Micro Biosystems' EBITDA (Quarter) stood at -$14.6 million in 2021, then decreased by 18.58% to -$17.3 million in 2022, then rose by 29.39% to -$12.2 million in 2023, then increased by 16.07% to -$10.2 million in 2024, then dropped by 11.17% to -$11.4 million in 2025.
  • Its EBITDA stands at -$11.4 million for Q3 2025, versus -$12.1 million for Q2 2025 and -$11.7 million for Q1 2025.